Annual Operating Expenses
$45.26 M
+$1.64 M+3.76%
December 31, 2023
Summary
- As of February 26, 2025, HEPA annual total operating expenses is $45.26 million, with the most recent change of +$1.64 million (+3.76%) on December 31, 2023.
- During the last 3 years, HEPA annual operating expenses has risen by +$25.11 million (+124.65%).
- HEPA annual operating expenses is now at all-time high.
Performance
HEPA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$4.46 M
-$4.05 M-47.57%
September 30, 2024
Summary
- As of February 26, 2025, HEPA quarterly total operating expenses is $4.46 million, with the most recent change of -$4.05 million (-47.57%) on September 30, 2024.
- Over the past year, HEPA quarterly operating expenses has dropped by -$6.21 million (-58.20%).
- HEPA quarterly operating expenses is now -75.41% below its all-time high of $18.13 million, reached on June 30, 2022.
Performance
HEPA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
HEPA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | -58.2% |
| 3 y3 years | +124.7% | -50.5% |
| 5 y5 years | +210.1% | -50.5% |
HEPA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.9% | -75.4% | at low |
| 5 y | 5-year | at high | +482.5% | -75.4% | +98.8% |
| alltime | all time | at high | +2606.7% | -75.4% | >+9999.0% |
Hepion Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.46 M(-47.6%) |
| Jun 2024 | - | $8.50 M(+64.1%) |
| Mar 2024 | - | $5.18 M(-28.2%) |
| Dec 2023 | $45.26 M(+3.8%) | $7.22 M(-32.3%) |
| Sep 2023 | - | $10.66 M(-24.7%) |
| Jun 2023 | - | $14.17 M(+7.2%) |
| Mar 2023 | - | $13.21 M(+35.2%) |
| Dec 2022 | $43.62 M(+43.5%) | $9.77 M(+15.4%) |
| Sep 2022 | - | $8.47 M(-53.3%) |
| Jun 2022 | - | $18.13 M(+149.9%) |
| Mar 2022 | - | $7.25 M(-19.4%) |
| Dec 2021 | $30.40 M(+50.9%) | $9.00 M(+5.7%) |
| Sep 2021 | - | $8.52 M(+24.3%) |
| Jun 2021 | - | $6.85 M(+13.6%) |
| Mar 2021 | - | $6.03 M(+21.8%) |
| Dec 2020 | $20.15 M(+159.3%) | $4.95 M(-20.5%) |
| Sep 2020 | - | $6.23 M(+30.5%) |
| Jun 2020 | - | $4.78 M(+14.1%) |
| Mar 2020 | - | $4.19 M(+86.7%) |
| Dec 2019 | $7.77 M(-46.8%) | $2.24 M(+17.4%) |
| Sep 2019 | - | $1.91 M(+12.7%) |
| Jun 2019 | - | $1.70 M(-11.8%) |
| Mar 2019 | - | $1.92 M(-35.8%) |
| Dec 2018 | $14.59 M(+38.7%) | $3.00 M(-22.2%) |
| Sep 2018 | - | $3.85 M(-0.8%) |
| Jun 2018 | - | $3.88 M(+0.6%) |
| Mar 2018 | - | $3.86 M(-33.9%) |
| Dec 2017 | $10.52 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $5.84 M(+11.9%) |
| Jun 2017 | $21.02 M(+1.0%) | $5.22 M(+6.3%) |
| Mar 2017 | - | $4.91 M(-18.5%) |
| Dec 2016 | - | $6.02 M(+23.5%) |
| Sep 2016 | - | $4.88 M(-15.8%) |
| Jun 2016 | $20.81 M(+49.0%) | $5.79 M(+24.5%) |
| Mar 2016 | - | $4.65 M(-15.6%) |
| Dec 2015 | - | $5.51 M(+13.8%) |
| Sep 2015 | - | $4.84 M(-9.9%) |
| Jun 2015 | $13.96 M(+734.9%) | $5.38 M(+22.2%) |
| Mar 2015 | - | $4.40 M(+41.7%) |
| Dec 2014 | - | $3.10 M(+186.8%) |
| Sep 2014 | - | $1.08 M(+24.5%) |
| Jun 2014 | $1.67 M | $869.50 K(+89.4%) |
| Mar 2014 | - | $459.00 K(+181.1%) |
| Dec 2013 | - | $163.30 K(-9.5%) |
| Sep 2013 | - | $180.40 K(-89.8%) |
| Dec 2011 | - | $1.77 M(+581.3%) |
| Sep 2011 | - | $260.40 K(-4.2%) |
| Jun 2011 | - | $271.90 K(+79.5%) |
| Mar 2011 | - | $151.50 K(-14.8%) |
| Dec 2010 | - | $177.90 K(+58.4%) |
| Sep 2010 | - | $112.30 K(-30.0%) |
| Jun 2010 | - | $160.40 K(+43.1%) |
| Mar 2010 | - | $112.10 K(+6.4%) |
| Dec 2009 | - | $105.40 K(-629.6%) |
| Sep 2009 | - | -$19.90 K(-297.0%) |
| Jun 2009 | - | $10.10 K(-54.5%) |
| Mar 2009 | - | $22.20 K |
FAQ
- What is Hepion Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual operating expenses year-on-year change?
- What is Hepion Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly operating expenses year-on-year change?
What is Hepion Pharmaceuticals annual total operating expenses?
The current annual operating expenses of HEPA is $45.26 M
What is the all time high annual operating expenses for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual total operating expenses is $45.26 M
What is Hepion Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, HEPA annual total operating expenses has changed by +$1.64 M (+3.76%)
What is Hepion Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of HEPA is $4.46 M
What is the all time high quarterly operating expenses for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly total operating expenses is $18.13 M
What is Hepion Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, HEPA quarterly total operating expenses has changed by -$6.21 M (-58.20%)